Janet L Stanford
Biographic Data
| ID | 10858618 |
|---|---|
| NAME | Janet L Stanford |
| GIVEN NAMES | Janet L |
| FAMILY NAME | Stanford |
| SIGNATURE | STANFORD J L |
| AFFILIATIONS | Fred Hutch Cancer Center |
| ORCID | 0000-0001-5062-4784 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1989 |
| LATEST PUBLICATION YEAR | 2000 |
| H-INDEX | 1 |
Validation Study of Retrospective Recall of Disease-Targeted Function
OBJECTIVES: This was an ancillary methodological study within the Prostate Cancer Outcomes Study (PCOS) to assess the validity of 6-month retrospective recall of prediagnostic disease-targeted function among men diagnosed with prostate cancer. METHODS: A convenience sample of 133 prostate cancer cases were administered a baseline questionnaire shortly after diagnosis that asked about prediagnostic urinary, sexual, and bowel function. They were su…
Breast cancer incidence in young women by estrogen receptor status and race
A population-based study was utilized to calculate breast cancer incidence rates in White and Black women, ages 30 to 54, according to tumor estrogen receptor status. Both racial groups had higher incidence curves for estrogen receptor negative breast cancer between ages 30 and 49. There was an excess of receptor negative cancer in young Black women, an observation that may help explain the racial disparity in breast cancer survival
Breast cancer incidence in young women by estrogen receptor status and race
A population-based study was utilized to calculate breast cancer incidence rates in White and Black women, ages 30 to 54, according to tumor estrogen receptor status. Both racial groups had higher incidence curves for estrogen receptor negative breast cancer between ages 30 and 49. There was an excess of receptor negative cancer in young Black women, an observation that may help explain the racial disparity in breast cancer survival
Breast cancer incidence in young women by estrogen receptor status and race
A population-based study was utilized to calculate breast cancer incidence rates in White and Black women, ages 30 to 54, according to tumor estrogen receptor status. Both racial groups had higher incidence curves for estrogen receptor negative breast cancer between ages 30 and 49. There was an excess of receptor negative cancer in young Black women, an observation that may help explain the racial disparity in breast cancer survival
Validation Study of Retrospective Recall of Disease-Targeted Function
OBJECTIVES: This was an ancillary methodological study within the Prostate Cancer Outcomes Study (PCOS) to assess the validity of 6-month retrospective recall of prediagnostic disease-targeted function among men diagnosed with prostate cancer. METHODS: A convenience sample of 133 prostate cancer cases were administered a baseline questionnaire shortly after diagnosis that asked about prediagnostic urinary, sexual, and bowel function. They were su…
Cancer (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Biology (1 work) · Black women (1 work) · BRCA gene mutations in cancer (1 work) · Breast cancer (1 work) · Cancer Risks and Factors (1 work) · Cancer survivorship and care (1 work)